| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |